As at Jul 26, 2024, the MEDP stock has a price-to-earnings ratio of 34.62. This is based on the current EPS of $11.02 and the stock price of $381.47 per share. The current PE ratio is comparable to the past four-quarter average.
The mean historical PE ratio of Medpace Holdings over the last eight years is 41.93. The current 34.62 P/E ratio is 17% lower than the historical average. In the past eight years, MEDP's PE ratio peaked in the Sep 2016 quarter at 248.83, with a price of $29.86 and an EPS of $0.12. The Mar 2023 quarter marked the lowest point at 22.99, with a price of $188.05 and an EPS of $8.18.
Maximum annual increase: 25.76% in 2021
Maximum annual decrease: -61.8% in 2017
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 33.32 | 18.75% |
| 2022 | 28.06 | -34.76% |
| 2021 | 43.01 | 25.76% |
| 2020 | 34.2 | 13.51% |
| 2019 | 30.13 | 16.69% |
| 2018 | 25.82 | -28.79% |
| 2017 | 36.26 | -61.8% |
| 2016 | 94.92 | N/A |
| 2015 | N/A | N/A |
The current PE ratio of MEDP is higher than its 3 and 5-year historical averages.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MEDP Medpace Holdings Inc | 34.62 | $11.83B |
| OMGA Omega Therapeutics Inc | N/A | $105.9M |
| ONCT Oncternal Therapeutics Inc | N/A | $20.98M |
The price to earnings ratio for MEDP stock is 34.62 as of Jul 26, 2024.
As an average over the last 3 years, MEDP stock has a PE ratio of 31.17.
As an average over the last 5 years, MEDP stock has a PE ratio of 31.54.
The highest quarterly PE ratio in the last eight years has been 248.83 and it was in the Sep 2016 quarter.
MEDP's current price to earnings ratio is 17% below its 8-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 26, 2024), Medpace Holdings's stock price is $381.47. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $11.02. Therefore, Medpace Holdings's PE ratio for today is 34.62. PE RATIO(34.62) = STOCK PRICE($381.47) / TTM EPS($11.02)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.